Peptide record

TPDB12097

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
45 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB12097
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 dbACP iACP-DRLF AFP-GFuse Antifungipept CAFPdb
standard
No
A 45-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLPKTLRKFFCRIRGGRCAVLNCLGKEEQIGRCSNSGRKCCRKKK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C221H380N76O56S6
DHMWY
RK
5190.28
10.86
14
2
11
+12
2.85
-0.636
60.67
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
375
0.07
12
Residue Composition
number
1
A
7
R
2
N
0
D
6
C
2
E
1
Q
5
G
0
H
2
I
4
L
7
K
0
M
3
F
1
P
2
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 7 N: 2 D: 0 C: 6 E: 2 Q: 1 G: 5 H: 0 I: 2 L: 4 K: 7 M: 0 F: 3 P: 1 S: 2 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
45 reviewed residue count
C221H380N76O56S6 sequence-only estimate (linear, free termini)
5190.28 sequence-only estimate (linear, free termini)
10.86 sequence-only estimate (linear, free termini)
+12 sequence-only estimate (linear, free termini)
2.85 sequence-only estimate (linear, free termini)
-0.636 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against Gram-positive bacteria S. aureus ATCC 12600, S. aureus ATCC 33593, S. epidermidis ATCC 14990, S. pyogenes ATCC 12344, E. faecalis ATCC 29212, E faecalis ATCC 51299 (anti-VRE) (MBC 1.2-2.4 uM), Gram-negative bacteria E. coli ATCC 11775, E. coli ATCC 25922, E. coli ESBL 4 (clinical isolate), S. enterica serovar Typhimurium ATCC 13311 (MBC 0.6-1.2 uM), P. aeruginosa ATCC 10145, P. aeruginosa Va 6201/2000 (multiresistant clinical isolate), and yeast C. albicans ATCC 24433 (MBC 1.2 uM). Like hBD-3, this peptide also displays chemotactic effects to cells expressing CCR2 or CCR6 receptors. Activation of this path could promote cell growth, including tumor cells Röhrl J, et al., 2012 . It has anticancer effect on lung cancer cells ( Hanaoka Y et al., 2016 Phan et al., 2016 ).
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against Gram-positive bacteria S. aureus ATCC 12600, S. aureus ATCC 33593, S. epidermidis ATCC 14990, S. pyogenes ATCC 12344, E. faecalis ATCC 29212, E faecalis ATCC 51299 (anti-VRE) (MBC 1.2-2.4 uM), Gram-negative bacteria E. coli ATCC 11775, E. coli ATCC 25922, E. coli ESBL 4 (clinical isolate), S. enterica serovar Typhimurium ATCC 13311 (MBC 0.6-1.2 uM), P. aeruginosa ATCC 10145, P. aeruginosa Va 6201/2000 (multiresistant clinical isolate), and yeast C. albicans ATCC 24433 (MBC 1.2 uM). Like hBD-3, this peptide also displays chemotactic effects to cells expressing CCR2 or CCR6 receptors. Activation of this path could promote cell growth, including tumor cells Röhrl J, et al., 2012 . It has anticancer effect on lung cancer cells ( Hanaoka Y et al., 2016 Phan et al., 2016 ).
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

DRAMP

Other

Active against Gram-positive bacteria S. aureus ATCC 12600, S. aureus ATCC 33593, S. epidermidis ATCC 14990, S. pyogenes ATCC 12344, E. faecalis ATCC 29212, E faecalis ATCC 51299 (anti-VRE) (MBC 1.2-2.4 uM), Gram-negative bacteria E. coli ATCC 11775, E. coli ATCC 25922, E. coli ESBL 4 (clinical isolate), S. enterica serovar Typhimurium ATCC 13311 (MBC 0.6-1.2 uM), P. aeruginosa ATCC 10145, P. aeruginosa Va 6201/2000 (multiresistant clinical isolate), and yeast C. albicans ATCC 24433 (MBC 1.2 uM). Like hBD-3, this peptide also displays chemotactic effects to cells expressing CCR2 or CCR6 receptors. Activation of this path could promote cell growth, including tumor cells Röhrl J, et al., 2012 . It has anticancer effect on lung cancer cells ( Hanaoka Y et al., 2016 Phan et al., 2016 ).
Evidence 4 Activity

Activity

Antiviral

Source & Reference

DRAMP

Other

Active against Gram-positive bacteria S. aureus ATCC 12600, S. aureus ATCC 33593, S. epidermidis ATCC 14990, S. pyogenes ATCC 12344, E. faecalis ATCC 29212, E faecalis ATCC 51299 (anti-VRE) (MBC 1.2-2.4 uM), Gram-negative bacteria E. coli ATCC 11775, E. coli ATCC 25922, E. coli ESBL 4 (clinical isolate), S. enterica serovar Typhimurium ATCC 13311 (MBC 0.6-1.2 uM), P. aeruginosa ATCC 10145, P. aeruginosa Va 6201/2000 (multiresistant clinical isolate), and yeast C. albicans ATCC 24433 (MBC 1.2 uM). Like hBD-3, this peptide also displays chemotactic effects to cells expressing CCR2 or CCR6 receptors. Activation of this path could promote cell growth, including tumor cells Röhrl J, et al., 2012 . It has anticancer effect on lung cancer cells ( Hanaoka Y et al., 2016 Phan et al., 2016 ).